Marinus B. Groen
Organon International
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marinus B. Groen.
European Journal of Medicinal Chemistry | 2000
Roberta Bursi; Marinus B. Groen
Progestagens are drugs, which are widely used in hormonal contraception and in hormone-replacement therapy. Since the natural hormone, progesterone, lacks oral activity, much effort has been devoted to finding analogues with improved oral activity and, preferably, higher potency and selectivity. A crystal structure of the hormone binding domain (HBD) region of the progesterone receptor (PR) could only be obtained recently. For more than forty years the process of designing new progestagens could therefore only be guided by the knowledge of the structure of the ligand and its corresponding in vitro/in vivo activities. While in early days chemical intuition and simple statistics (structure-activity relationship - SAR) were leading the drug design process, in later days more complex statistics and visualization tools have become routinely part of quantitative structure-activity relationship (QSAR) studies. The present review aims to provide a general overview of the strategies, efforts and achievements of synthetic and computational chemists in more than forty years of development of progestagens.
Tetrahedron Letters | 1980
Marinus B. Groen; J. Leemhuis
Abstract The synthesis of trans-( + )- and (−)-3,4-bis [(3-hydroxyphenyl) methyl] dihydro-2-(3H)-furanone ( 1 ), a recently discovered constituent of female urine, and some related compounds of biological interest is described.
Tetrahedron Letters | 1982
Marinus B. Groen; F.J. Zeelen
Abstract A total synthesis of the novel steroids DL-14α-methylestradiol ( 9 ) and DL-14α-methyl-19-nortestosterone ( 11 ) via cationic cyclization is described. Advantage was taken of the unusual stereoselectivity of Mo(CO) 6 / t -BuOOH epoxidations.
Steroids | 2004
V. A. Khripach; Vladimir N. Zhabinskii; Galina P. Fando; Alla I Kuchto; Alexander S. Lyakhov; Alla A. Govorova; Marinus B. Groen; Jaap van der Louw; Aede de Groot
A synthetic methodology for the synthesis of 13,14-seco-steroids with substituents at C-14 and C-17 is described. The approach involves Grob fragmentation of 14beta-hydroxy-17beta-tosylates, hydroboration-oxidation of the intermediate delta13(17)-olefin, and hydride reduction of the 14-ketone. An unambiguous structural assignment of (13R,14S,17S)-14,17-diacetoxy-3-methoxy-7alpha-methyl-13,14-secoestra-1,3,5(10)-triene was determined by X-ray analysis.
Steroids | 2004
V. A. Khripach; Vladimir N. Zhabinskii; Anna I. Kuchto; Galina P. Fando; Yuliya Y. Zhiburtovich; Alexander S. Lyakhov; Alla A. Govorova; Marinus B. Groen; Jaap van der Louw; Aede de Groot
The synthesis of 13,14-seco steroids starting from easily available (13S)-13-iodo-6-methoxy-3,5-cyclo-13,14-seco-5-androsta-14,17-dione is described. The C-17 ketone was converted regioselectively into its oxime with simultaneous stereoselective deiodination at C-13. The remaining C-14 carbonyl group was then reduced stereoselectively with Ca(BH4)2. The configurations at the relevant stereocenters of the thus obtained hydroxy oxime were determined by X-ray analysis. Successful regeneration of the C-17 carbonyl group was achieved by treatment of the corresponding oxime acetate with TiCl3.
Steroids | 2004
V. A. Khripach; Vladimir N. Zhabinskii; Anna I. Kuchto; Yuliya Y. Zhiburtovich; Galina P. Fando; Alexander S. Lyakhov; Alla A. Govorova; Marinus B. Groen; Jaap van der Louw; Aede de Groot
A number of testosterone analogs with a 13,14-secosteroidal fragment have been prepared from (13S)-13-iodo-6beta-methoxy-3alpha, 5-cyclo-13,14-seco-5alpha-androstan-14,17-dione. The key steps involved stereoselective deiodination of the starting compound with triphenylphosphine and selective protection of the 17-keto group with trimethylsilylcyanide. Removal of iodine at C-13 proceeded with inversion of the configuration at C-13, which has been established by X-ray crystallography. 13,14-Secotestosterone analogues substituted and non-substituted at C-14 have been prepared. The obtained compounds containing flexible CD ring fragments are of great interest for comparative studies in biological tests together with testosterone and other steroids with a rigid tetracyclic skeleton.
Steroids | 1992
A.I.A. Broess; Nico P. van Vliet; Marinus B. Groen; Hans Hamersma
The effect of a substituent in the 12-position of progestagens was studied. To this end, various approaches toward the preparation of 12 beta-alkyl- and 12-alkylidenenorpregnanes were investigated. Eventually, the desired compounds 17 beta-hydroxy-12 beta-methyl-18a-homo-19-nor-17 alpha-pregn-4-en-20-yn-3-one (37) and 17 beta-hydroxy-12-methylene-18a-homo-19-nor-17 alpha-pregn-4-en-20-yn- 3-one (38) were obtained in racemic form by total synthesis; they were shown to lack progestagenic activity.
Tetrahedron Letters | 2001
N.Miranda Teerhuis; Inès A.M Huisman; Marinus B. Groen
Abstract The synthesis of ent -19-nortestosterone from natural 19-nortestosterone is described. The synthetic sequence takes advantage of the ‘near symmetry’ properties of the steroid; removal/introduction of a methyl group and conversion of the A- into the D-ring and vice versa eventually results in overall inversion of the stereochemistry.
Bioorganic & Medicinal Chemistry | 2001
D.R Boer; Huub Kooijman; J van der Louw; Marinus B. Groen; Jan Kelder; Jan Kroon
Follicular Fluid-Meiosis Activating Sterol (FF-MAS) is a compound important for maturation of gametes in mammals. Therefore, it may serve as a lead compound for a novel method of contraception. We studied the Molecular Electrostatic Potential of a series of active and inactive analogues of FF-MAS. We find that double bond configurations required for activity result in a local negative electrostatic potential which is larger as well as more dense compared to those of inactive molecules. We therefore hypothesize that the interaction energy of the double bond system of the MAS compounds with its receptor substantially contributes to the overall interaction energy. This notion is supported by interaction studies of the electrostatic potential originating from the double bonds in crystal structures of cholesterol and four MAS-derived Delta(8,14) structures synthesized and crystallized by us. In addition, we were able to derive a pharmacophore model that relates the local average ESP and its distance to the 3beta-OH oxygen atom to the activity of the molecules.
Steroids | 2006
V. A. Khripach; Vladimir N. Zhabinskii; Anna I. Kuchto; Yuliya Y. Zhiburtovich; Alexander S. Lyakhov; Alla A. Govorova; Marinus B. Groen; Jaap van der Louw; Aede de Groot
Three new products have been isolated from the lead-tetraacetate version of the hypoiodite oxidation of 3beta,17beta-diacetoxy-5-hydroxy-5 alpha-androstane. Along with the expected 1(10)-unsaturated 5,10-seco steroidal 5-ketones, the fragmentation reaction gave two epimeric C-4 iodides. Their structural assignment was based on X-ray data of one of them ((4R,10S)-4-iodo-3beta,17beta-diacetoxy-5,10-secoandrostan-5-one). The third new product was found to be the 5 beta,6 beta-epoxide resulting from the dehydration of the tertiary alcohol followed by epoxidation of the intermediate Delta(5)-olefin.